What You Should Know:
- Using the EHR-integrated app, Desert Oasis Healthcare efficiently identifies patients with possible Coronavirus symptoms, mitigating the spread, and optimizing treatment.
- Starting in mid-March, DOHC has leveraged Rimidi’s novel, Fast Healthcare Interoperability Resources (FHIR) based patient-reported outcomes (PROs) tool.
- To date, over 7,400 patients have been screened prior
to their appointments and 831 have been monitored during self-isolation due
Read More
Boston Medical, Rimidi Partner to Tackle High-Risk Pregnancy During COVID-19
What You Should Know:
- To help overcome the challenges of high-risk pregnancies, Boston Medical Center announced a partnership with Rimidi, a cloud-based software platform, to enable physicians to remotely collect and analyze patient-generated data to better treat patients remotely.
- Throughout the COVID-19 pandemic and beyond, the adoption of Rimidi’s platform will ease fears and provide an extra layer of medical support by leveraging remote monitoring capabilities.
Boston
Read More
Rimidi Launches COVID-19 Screening App to Identify At-Risk Patients & Limit Exposure
What You Need to Know:
- To limit the spread of COVID-19 in healthcare settings, Rimidi has developed a Coronavirus (COVID-19) screening application for health systems to identify at-risk patients and direct them to appropriate locations.
- The EHR-integrated app is one of the first designed specifically to flag patients with possible Coronavirus symptoms, enabling health systems to mitigate the spread and optimize treatment.
Rimidi, a cloud-based
software platform, today
Read More
HIMSS Names The 6 Most Influential Women in Health IT
HIMSS names
Iris P. Frye, Kim Garriott, Dr. Lucienne Ide, Eva Karp, RN-BC, Dr. Geeta Nayyar,
and Tressa Springmann as the most influential women in health IT.
This week, HIMSS announced its Most Influential Women in Health IT, an annual recognition celebrating women striving to harness the power of information technology to drive healthcare transformation. The award winners will be honored at HIMSS20 in Orlando next month and will join other innovators, leaders, and entrepreneurs at the
Read More
Rimidi Adds Obesity View to EHR-Integrated Platform for Clinicians
- Rimidi adds Obesity disease view to its platform to preemptively identify and manage cardiometabolic diseases by combining data from multiple sources into disease ‘views’ that provide a holistic overview of a patient.- With the obesity view, clinicians are better equipped to identify and lower the potential health risks impacting patients- The addition of obesity to Rimidi’s platform addresses the evolving policies and care around obesity, as the chronic disease requires increased medical
Read More
Rimidi Adds Aggregated Cardiovascular Disease EHR Data to Platform
Across the United States, cardiovascular disease (CVD) continues to threaten populations. It’s the leading cause of death, with nearly half of all U.S. adults suffering from some form of CVD. Rimidi, a cloud-based software platform that enables personalized management of chronic cardiometabolic conditions across the population has expanded its cloud-based platform to include a view for CVD. Working within the electronic health record (EHR) workflow, clinicians can seamlessly navigate between the
Read More
Companion Medical Integrates Smart Insulin Pen with Rimidi Diabetes Management App
Rimidi and Companion Medical announced a first-of-its-kind partnership to enhance data visualization for clinicians treating high-risk patients with diabetes who are on insulin therapy. The collaboration integrates Companion Medical’s connected device, InPen™, the first and only FDA-cleared, smart insulin pen paired with an integrated diabetes management app, into Rimidi’s platform by pushing insulin dosing data from the InPen through the cloud.Integration BenefitsThis partnership reduces the
Read More
Rimidi, BodyTrace Partner to Provide Cellular-Enabled Scales to Heart Failure Patients
Rimidi has partnered with BodyTrace, a cellular technology company, to provide cellular-enabled scales to heart failure patients who are remotely monitored by their clinicians using Rimidi's software platform. The cellular scales provide a frictionless experience for patients; all they have to do is step on the scale and their weight is automatically transmitted to the Rimidi platform, where their care team can monitor changes in weight that may indicate fluid retention and worsening heart
Read More
Rimidi Raises $6.575M for Cloud-based Enterprise Solution for Diabetes Management
Rimidi, Inc.(formerly known as Rimidi Diabetes), an Atlanta-based digital health startup that provides software and clinical analytics for chronic disease management, announced it has raised $6.575 million in Series A-1 financing, which includes a strategic investment by Eli Lilly and Company, an investment from Turner Investments, and participation from existing investors Cox Enterprises, Village Capital, The Jump Fund, and JAMB Global. The company plans to use the funding round to fuel growth
Read More
